SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Pacira Biosciences, Inc. – PCRX

NEW YORK, NY / ACCESS Newswire / January 18, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Pacira Biosciences, Inc. ("Pacira" or the "Company") (NASDAQ:PCRX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged […]

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Nextracker Inc. of Class Action Lawsuit and Upcoming Deadlines – NXT

NEW YORK, NY / ACCESS Newswire / January 18, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Nextracker Inc. ("Nextracker" or the "Company") (NASDAQ:NXT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Nextracker and certain of its officers and/or directors have

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Micron Technology, Inc. of Class Action Lawsuit and Upcoming Deadlines – MU

NEW YORK CITY, NY / ACCESS Newswire / January 18, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Micron Technology, Inc. ("Micron" or the "Company") (NASDAQ:MU) and certain officers. The class action, filed in the United States District Court for the Southern District of Florida, and docketed under 25-cv-80040,

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of First Northwest Bancorp – FNWB

NEW YORK, NY / ACCESS Newswire / January 18, 2025 / Pomerantz LLP is investigating claims on behalf of investors of First Northwest Bancorp ("FNWB" or the "Company") (NASDAQ:FNWB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether FNWB and certain of its officers and/or directors

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neurogene Inc. – NGNE

NEW YORK, NY / ACCESS Newswire / January 18, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Neurogene Inc. ("Neurogene" or the "Company") (NASDAQ:NGNE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Neurogene and certain of its officers and/or directors have

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Spyre Therapeutics, Inc. – SYRE

NEW YORK, NY / ACCESS Newswire / January 18, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Spyre Therapeutics, Inc. ("Spyre" or the "Company") (NASDAQ:SYRE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Spyre and certain of its officers and/or directors

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of e.l.f. Beauty, Inc. – ELF

NEW YORK, NY / ACCESS Newswire / January 18, 2025 / Pomerantz LLP is investigating claims on behalf of investors of e.l.f. Beauty, Inc. ("e.l.f. Beauty" or the "Company") (NYSE:ELF). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether e.l.f. Beauty and certain of its officers

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oklo Inc. – OKLO

NEW YORK, NY / ACCESS Newswire / January 18, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Oklo Inc. ("Oklo" or the "Company") (NYSE:OKLO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Oklo and certain of its officers and/or directors have

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Walmart Inc. – WMT

NEW YORK, NY / ACCESS Newswire / January 18, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Walmart Inc. ("Walmart" or the "Company") (NYSE:WMT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Walmart and certain of its officers and/or directors have

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – APLT

NEW YORK CITY, NY / ACCESS Newswire / January 18, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ:APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail

Scroll to Top